Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Mallinckrodt
Cipla
Cerilliant
Dow
Federal Trade Commission
Merck
Farmers Insurance
Queensland Health
Deloitte

Generated: February 25, 2018

DrugPatentWatch Database Preview

OCTREOTIDE ACETATE Drug Profile

« Back to Dashboard

When do Octreotide Acetate patents expire, and what generic alternatives are available?

Octreotide Acetate is a drug marketed by Fresenius Kabi Usa, Sagent Pharms, Sun Pharm Inds, Teva Pharms Usa, West-ward Pharms Int, Wockhardt Usa, and Mylan Institutional. and is included in sixteen NDAs.

The generic ingredient in OCTREOTIDE ACETATE is octreotide acetate. There are nineteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
Drug patent expirations by year for OCTREOTIDE ACETATE
Pharmacology for OCTREOTIDE ACETATE
Medical Subject Heading (MeSH) Categories for OCTREOTIDE ACETATE

US Patents and Regulatory Information for OCTREOTIDE ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sagent Pharms OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 090834-003 Nov 12, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 079198-002 Feb 10, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 076313-001 Mar 28, 2005 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 079198-003 Feb 10, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 077450-001 Feb 10, 2006 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 075957-003 Oct 3, 2005 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa OCTREOTIDE ACETATE (PRESERVATIVE FREE) octreotide acetate INJECTABLE;INJECTION 077457-001 Feb 10, 2006 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 077329-002 Mar 4, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wockhardt Usa OCTREOTIDE ACETATE PRESERVATIVE FREE octreotide acetate INJECTABLE;INJECTION 090985-001 May 11, 2011 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sagent Pharms OCTREOTIDE ACETATE octreotide acetate INJECTABLE;INJECTION 091041-002 Nov 12, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for OCTREOTIDE ACETATE
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Injection 0.05 mg/mL (base), 0.1 mg/mL (base) and 0.5 mg/mL (base) packaged in 1 mL pre-fi ➤ Subscribe 1/17/2008

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Mallinckrodt
Baxter
McKinsey
Healthtrust
Covington
Julphar
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot